Shree Ganesh Remedies Ltd.

View in App
511.90 +1.30 ▲0.3%

22 September 2023, 04:01:00 PM
Volume: 8,755

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ganeshremedies.com
Market Cap 657.65 Cr.
Enterprise Value(EV) 680.01 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 14.72 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 34.79 Trailing Twelve Months Ending 2023-06
Industry PE 37.50 Trailing Twelve Months Ending 2023-06
Book Value / Share 73.19 Trailing Twelve Months Ending 2023-06
Price to Book Value 6.99 Calculated using Price: 511.90
Dividend Yield 0.10 Period Ending 2023-03
No. of Shares Subscribed 1.28 Cr. 12,847,198 Shares
FaceValue 10
About Shree Ganesh Remedies Ltd.
The company is as ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

Shree Ganesh Remedies Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Shree Ganesh Remedies Ltd. Performance

View details >>
1 Day
+0.25%
1 Week
-0.81%
1 Month
+18.56%
3 Month
+28.76%
6 Month
+112.32%
1 Year
+110.56%
2 Year
+49.44%
5 Year
+1022.10%
10 Year

Shree Ganesh Remedies Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 10.38 8.06 17.31 20.75 19.95 25.35 21.18 24.02 22.62
Return on Capital Employed (%) 16.15 12.42 26.15 27.68 27.04 32.63 27.51 32.47 24.67
Return on Assets (%) 8.56 7.01 14.34 16.52 16.20 20.56 17.29 19.47 15.42

Shree Ganesh Remedies Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 12 13 14 17 29 34 42 50 62 89
Non Curr. Liab. 0 0 0 0 0 1 0 0 0 31
Curr. Liab. 3 2 2 4 7 7 10 10 15 24
Minority Int.
Equity & Liab. 15 15 16 21 36 41 52 61 77 144
Non Curr. Assets 5 5 5 5 7 16 17 23 32 79
Curr. Assets 10 10 11 17 28 26 35 38 45 64
Misc. Exp. not W/O
Total Assets 15 15 16 21 36 41 52 61 77 144

Shree Ganesh Remedies Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 17 16 20 27 35 58 49 71 90 99
Other Income 0 0 0 2 1 4 2 4 3 3
Total Income 17 16 20 29 36 63 51 75 93 103
Total Expenditure -14 -14 -16 -22 -27 -47 -35 -53 -67 -74
PBIDT 3 2 5 7 10 15 16 21 26 29
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -2 -3 -3 -4 -4
Taxation -1 -1 -1 -2 -2 -3 -3 -5 -6 -6
Exceptional Items
PAT 1 1 3 5 6 10 10 13 17 19
Adjusted EPS 1 1 3 4 5 8 8 11 14 15

Shree Ganesh Remedies Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 -5 4 3 13 17
Cash Fr. Inv. -3 0 -3 -1 -12 -54
Cash Fr. Finan. 8 0 0 -1 -1 41
Net Change 4 -5 1 2 0 5
Cash & Cash Eqvt 6 1 2 3 4 9

Shree Ganesh Remedies Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 68.39 69.12 69.12 69.12 69.12 68.27 68.27 69.33 69.33
Public 31.61 30.88 30.88 30.88 30.88 31.73 31.73 30.67 30.67
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Shree Ganesh Remedies Ltd. Announcements

View details >>
Thu, 21 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst /Institutional Investor Meetings
Mon, 18 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 28th Annual General Meeting
Mon, 18 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting Results Pursuant to Regulation 44(3) of SEBI Listing Regulations 2015

Shree Ganesh Remedies Ltd. Technical Scans

View details >>
Fri, 22 Sep 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Shree Ganesh Remedies Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,508.75 1,131.60 -1.3%
Divi's Laboratories Ltd. 98,393.27 3,708.40 -1.0%
Cipla Ltd. 95,796.29 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. 92,004.31 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. 71,703.97 5,003.05 -0.3%
Mankind Pharma Ltd. 70,167.07 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. 62,653.02 1,853.55 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.19 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 66.64 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 30.73 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.48 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 107.60 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 54.74 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.79 1,853.55 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-06 7.50 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-06 3.93 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.75 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.47 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 5.73 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.54 1,853.55 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,853.55 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,853.55 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,131.60 -1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,708.40 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,184.35 -1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,516.35 -2.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,003.05 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,751.60 +0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,853.55 -1.1%

Shree Ganesh Remedies Ltd. FAQ's

What is Shree Ganesh Remed. share price?
Can I buy Shree Ganesh Remed. shares now?
What is the Dividend Yield of Shree Ganesh Remed.?
What is the Market Cap of Shree Ganesh Remed.?
What are the key metrics to analyse Shree Ganesh Remed.?
What is the 52 Week High and Low of Shree Ganesh Remed.?
What is the trend of Shree Ganesh Remed. share price?